ClinicalTrials.Veeva

Menu

Dual Subsartorial Versus Adductor Canal Block Versus Femoral Nerve Block for Postoperative Analgesia in Patients Undergoing Total Knee Arthroplasty

T

Tanta University

Status

Enrolling

Conditions

Postoperative Analgesia
Femoral Nerve Block
Adductor Canal Block
Dual Subsartorial Block
Total Knee Arthroplasty

Treatments

Other: Dual subsartorial block
Other: Adductor canal block
Other: Femoral nerve block

Study type

Interventional

Funder types

Other

Identifiers

NCT07082374
36264PR1260/6/25

Details and patient eligibility

About

This study aims to compare the effect of dual subsartorial block (DSB), adductor canal block (ACB), and femoral nerve block (FNB) for postoperative analgesia in patients undergoing total knee arthroplasty (TKA).

Full description

Total knee arthroplasty (TKA) offers increased joint mobility and painless ambulation to patients. Femoral nerve block (FNB) is commonly used to relieve postoperative pain and opioid consumption.

Adductor canal block (ACB) is a common analgesic intervention for postoperative pain control following TKA. The dual subsartorial block (DSB) is a novel procedure-specific and motor-sparing regional analgesia (RA) technique that may reduce overall postoperative opioid consumption when used in conjunction with multimodal analgesia.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age from 18 to 75 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status I-II.
  • Undergoing total knee arthroplasty (TKA) under general anesthesia.

Exclusion criteria

  • Severe valgus deformity.
  • Acute/chronic kidney disease.
  • Neurological deficit.
  • Cognitive dysfunction.
  • Local infection at the site of injection.
  • Coagulopathy.
  • Hypersensitivity and/or allergies to local anesthetic (LA) or any of the study medications.
  • Chronic opioid consumption (daily or almost daily use of opioids for > three months).
  • Operative limb neuropathy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 3 patient groups

DSB group
Experimental group
Description:
Patients will receive dual subsartorial block (DSB).
Treatment:
Other: Dual subsartorial block
ACB group
Experimental group
Description:
Patients will receive an adductor canal block (ACB).
Treatment:
Other: Adductor canal block
FNB group
Experimental group
Description:
Patients will receive a femoral nerve block (FNB).
Treatment:
Other: Femoral nerve block

Trial contacts and locations

1

Loading...

Central trial contact

Mohammed S ElSharkawy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems